'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end. (Q38995855)

From Wikidata

Revision as of 12:37, 21 June 2021 by YoaR (talk | contribs) (‎Changed Asturian description: artículu científicu espublizáu en 2014, batch #57022)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on August 2014

Language	Label	Description	Also known as
English	'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end.	scientific article published on August 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Xander M R van Wijk

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Arie Oosterhof

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Elly M M Versteeg

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Els M A van de Westerlo

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Toin H van Kuppevelt

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

1 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Biochemical Journal

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

461

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

461-468

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Heparan sulphate proteoglycans fine-tune mammalian physiology

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Order out of chaos: assembly of ligand binding sites in heparan sulfate

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Heterogeneity of heparan sulfates in human lung

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

A 4-deoxy analogue of N-acetyl-D-glucosamine inhibits heparan sulphate expression and growth factor binding in vitro

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Interfering with UDP-GlcNAc metabolism and heparan sulfate expression using a sugar analogue reduces angiogenesis

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Specificity studies on the heparin lyases from Flavobacterium heparinum

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Action pattern of polysaccharide lyases on glycosaminoglycans.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Characterizing the non-reducing end structure of heparan sulfate

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Glycomics analysis of mammalian heparan sulfates modified by the human extracellular sulfatase HSulf2.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Characterization of anticoagulant heparinoids by immunoprofiling

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Aberrant heparan sulfate profile in the human diabetic kidney offers new clues for therapeutic glycomimetics

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140355

21 January 2018

Identifiers

10.1042/BJ20140355

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38995855&oldid=1445873686"